Abstract
To determine whether decreased cardiac parasympathetic activity observed in obesity is due to insulin-induced alterations in cardiac M2-muscarinic receptors and/or adenylyl cyclase activity. After incubation with increasing concentrations of insulin, adult rat atrial cardiomyocytes were assayed for M2-muscarinic receptor binding density and affinity, and for M2R mRNA expression using RT-PCR analysis. Forskolin-stimulated adenylyl cyclase activity and its inhibition by carbachol were also assayed, as was endothelial nitric oxide synthase mRNA expression. The effects of insulin on M2-muscarinic receptor density and mRNA expression levels were analyzed using the insulin signaling inhibitors rapamycin, wortmanin and PD 098059. Insulin induces a concentration- and time-dependent decrease in expression of the M2R mRNA, and in [3H]N-methylscopolamine binding by the receptor. These effects on the M2R mRNA levels and on [3H]N-methylscopolamine binding were prevented by PD 98059, but not by wortmanin or rapamycin. Basal and forskolin-induced cAMP production did not differ, but the inhibition of forskolin-simulated enzyme activity by carbachol was blunted by insulin. No change in the mRNA levels for endothelial nitric oxide synthase was observed. In rat atrial cardiomyocytes, insulin markedly alters both the M2-muscarinc receptor density, and its mRNA expression through transcriptional regulation and adenylyl cyclase activity. These data suggest that the obesity-associated decrease in cardiac parasympathetic tone may be related to hyperinsulinemia, which could directly contribute to cardiovascular morbidity in obese patients.

This publication has 42 references indexed in Scilit: